| Item 1. | |
| (a) | Name of issuer:
Corcept Therapeutics Incorporated |
| (b) | Address of issuer's principal executive offices:
101 Redwood Shores Parkway, Redwood City, CA 94065 |
| Item 2. | |
| (a) | Name of person filing:
This statement is filed on behalf of Dr. Joseph K. Belanoff (the "Reporting Person"). |
| (b) | Address or principal business office or, if none, residence:
The business address of the Reporting Person is c/o Corcept Therapeutics Incorporated, 101 Redwood Shores Parkway, Redwood Shores, CA 94065. |
| (c) | Citizenship:
The Reporting Person is a citizen of the United States. |
| (d) | Title of class of securities:
Common Stock |
| (e) | CUSIP No.:
218352102 |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
| (a) |  Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
|
| (b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
|
| (c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
|
| (d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
|
| (e) | An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
|
| (f) | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
|
| (g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
|
| (h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
| (i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
| (j) | A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
|
| (k) | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
|
| | |
| Item 4. | Ownership |
| (a) | Amount beneficially owned:
The Reporting Person beneficially owns 6,822,335 shares of Common Stock, which consist of (i) 3,022,335 shares of Common Stock and (ii) 3,800,000 shares of Common Stock underlying stock options that are exercisable prior to March 1, 2025. |
| (b) | Percent of class:
6.3% |
| (c) | Number of shares as to which the person has:
|
| | (i) Sole power to vote or to direct the vote:
3,800,000
|
| | (ii) Shared power to vote or to direct the vote:
3,022,335
|
| | (iii) Sole power to dispose or to direct the disposition of:
3,800,000
|
| | (iv) Shared power to dispose or to direct the disposition of:
3,022,335
|
| Item 5. | Ownership of 5 Percent or Less of a Class. |
| |
Not Applicable
|
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. |
| |
Not Applicable
|
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
| |
Not Applicable
|
| Item 8. | Identification and Classification of Members of the Group. |
| |
Not Applicable
|
| Item 9. | Notice of Dissolution of Group. |
| |
Not Applicable
|
Rule 13d-1(d)